• March 2022: Lu-177 vipivotide tetraxetan & Ga-68 gozetotide receive FDA approval for prostate cancer
  • May 2020: Cerianna (F-18 fluoroestradiol) receives FDA approval for ER+ breast cancer imaging
  • Access the latest issues of the JNM and the JNMT
  • Learn about the Facilitating Innovative Nuclear Diagnostics (FIND) Act
  • March 2021:SNMMI Statement on COVID-19 and Ventilation/Perfusion (V/Q) Lung Studies
  • March 2021:SNMMI Statement: The Effect of COVID-19 Vaccination on FDG PET/CT

Events and Educational Opportunities


Details about outside events and educational opportunities available to MVC members are presented here.

***Please note:   this is informational only. The events listed here are not endorsed by the MVC but are shared with the members as a courtesy to receive training and continuing education.




If you have information about events and educational opportunities that may be of interest to MVC members, please contact the MVC Executive Director.